Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Elder

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|August 31, 2022
Obligate and Potential Precursors of MelanomaDavid E Elder
Journal of Cutaneous Pathology|November 3, 2024
Melanoma Diagnosis in the Mihm Era-And BeyondDavid E Elder
Pathology|September 17, 2004
The approach to the patient with a difficult melanocytic lesionDavid E Elder, Xiaowei Xu
American Journal of Clinical Pathology|August 10, 2004
A practical approach to selected problematic melanocytic lesionsXiaowei Xu, David E Elder
JAMA Dermatology|June 30, 2021
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently AppliedMark C Mochel, David E Elder
Journal of the National Cancer Institute|January 25, 2020
Staging for Melanoma - Toward a New Paradigm?David E Elder, Giorgos Karakousis, Richard A Scolyer
Dermatologic Therapy|November 22, 2005
Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic featuresDavid E Elder, Phyllis A Gimotty, DuPont Guerry
American Journal of Clinical Pathology|October 12, 2002
Validation of prognostic models for melanomaPhyllis A Gimotty, DuPont Guerry, David E Elder
Archives of Pathology & Laboratory Medicine|September 4, 2003
Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumorsXiaowei Xu, Paul J Zhang, David E Elder
Journal of the American Academy of Dermatology|August 17, 2014
Reply: surgical margins for possibly malignant melanocytic lesions and the overdiagnosis of melanomaMichael W Piepkorn, Raymond L Barnhill, David E Elder
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|August 31, 2022
Obligate and Potential Precursors of MelanomaDavid E Elder
Journal of Cutaneous Pathology|November 3, 2024
Melanoma Diagnosis in the Mihm Era-And BeyondDavid E Elder
Pathology|September 17, 2004
The approach to the patient with a difficult melanocytic lesionDavid E Elder, Xiaowei Xu
American Journal of Clinical Pathology|August 10, 2004
A practical approach to selected problematic melanocytic lesionsXiaowei Xu, David E Elder
JAMA Dermatology|June 30, 2021
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently AppliedMark C Mochel, David E Elder
Journal of the National Cancer Institute|January 25, 2020
Staging for Melanoma - Toward a New Paradigm?David E Elder, Giorgos Karakousis, Richard A Scolyer
Dermatologic Therapy|November 22, 2005
Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic featuresDavid E Elder, Phyllis A Gimotty, DuPont Guerry
American Journal of Clinical Pathology|October 12, 2002
Validation of prognostic models for melanomaPhyllis A Gimotty, DuPont Guerry, David E Elder
Archives of Pathology & Laboratory Medicine|September 4, 2003
Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumorsXiaowei Xu, Paul J Zhang, David E Elder
Journal of the American Academy of Dermatology|August 17, 2014
Reply: surgical margins for possibly malignant melanocytic lesions and the overdiagnosis of melanomaMichael W Piepkorn, Raymond L Barnhill, David E Elder
Pageof 18